Christina Bender

Christina Bender currently serves as Associate Director of Global Oncology Marketing with a focus on Biomarker Strategy at Daiichi Sankyo, Inc., since November 2022. Prior to this role, Christina held several significant positions at Bristol Myers Squibb, including Director of Commercial Operations and KPI Analytics for Hematology / Cell and Gene Therapy, and Director of Worldwide Exploratory Biomarker Strategy, demonstrating expertise in commercial operations and biomarker strategies. Further experience includes various leadership roles at Novartis, encompassing Global Oncology Precision Medicine and Commercial Pipeline Strategy, as well as positions in business analysis and market research. Earlier in Christina's career, roles at Eisai Pharmaceuticals Inc. and Gyros Protein Technologies AB provided foundational experience in marketing research and genomics. Christina holds a B.S. in Biological Science / Biochemistry from UCLA, a PhD in Biochemistry and Molecular Biology / Oncology from the University of Southern California, and an Executive MBA in Pharmaceutical Marketing and Business Management from Rutgers University - Newark.